{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:37:49Z","timestamp":1791322669689,"version":"4.3.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"vor","delay-in-days":397,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jval.2012.06.009","type":"journal-article","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T12:15:59Z","timestamp":1347970559000},"page":"982-986","source":"Crossref","is-referenced-by-count":44,"title":["An Evaluation Framework for Funding Drugs for Rare Diseases"],"prefix":"10.1016","volume":"15","author":[{"given":"Eric","family":"Winquist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Sabharwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Gadhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2012.06.009_bib1","author":"Miller"},{"key":"10.1016\/j.jval.2012.06.009_bib2","first-page":"595","article-title":"Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario","volume":"165","author":"Clarke","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.jval.2012.06.009_bib3","series-title":"Vue Weekly","article-title":"Hunter's syndrome becomes the hunted","author":"Saltel","year":"2007"},{"key":"10.1016\/j.jval.2012.06.009_bib5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2125.2006.02654.x","article-title":"Are rare diseases still orphans or happily adopted?","volume":"62","author":"Dear","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jval.2012.06.009_bib8","author":"Priest"},{"key":"10.1016\/j.jval.2012.06.009_bib9","series-title":"Setting limits fairly: can we learn to share medical resources","author":"Daniels","year":"2002"},{"key":"10.1016\/j.jval.2012.06.009_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(04)17098-0","article-title":"Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial","volume":"364","author":"Verweij","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2012.06.009_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(06)69446-4","article-title":"Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial","volume":"368","author":"Demetri","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jval.2012.06.009_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2012.06.009_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","article-title":"Surrogate endpoints in clinical trials: are we being misled?","volume":"125","author":"Fleming","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2012.06.009_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/003591576505800503","article-title":"The environment and disease: association or causation?","volume":"58","author":"Bradford Hill","year":"1965","journal-title":"Proc Royal Soc Med"},{"key":"10.1016\/j.jval.2012.06.009_bib16","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jval.2012.06.009_bib17","series-title":"Quality of Life Assessment in Clinical Trials: Methods and Practice","article-title":"Introduction to decision theory and utilities","author":"Sonnenberg","year":"1998"},{"key":"10.1016\/j.jval.2012.06.009_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/qjmed\/hci128","article-title":"Drugs for exceptionally rare diseases: do they deserve special status for funding?","volume":"98","author":"Hughes","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.jval.2012.06.009_bib20","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.331.7523.1019","article-title":"Commissioning for rare diseases: view from the frontline","volume":"331","author":"Burls","year":"2005","journal-title":"BMJ"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301512016221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301512016221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T23:31:36Z","timestamp":1594683096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301512016221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1098301512016221"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2012.06.009","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}